Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/46843
Conference/Presentation Title: Hypo-Attenuated Leaflet Thickening (HALT) is Associated With Structural Valve Deterioration (SVD) Following Transcatheter Aortic Valve Replacement (TAVR).
Authors: Rashid H.;Ramnarain J.;Nicholls S. ;Nasis A. ;Cameron J. ;Gooley R. 
Monash Health Department(s): Cardiology (MonashHeart)
Institution: (Rashid, Ramnarain, Nicholls, Nasis, Cameron, Gooley) MonashHeart, Monash Health, Mulgrave, Vic, Australia
Presentation/Conference Date: 10-Mar-2022
Publisher: Elsevier Ltd
Publication information: Heart Lung and Circulation. Conference: 69th CSANZ Annual Scientific Meeting 43rd Annual Scientific Meeting of the International Society for Heart Research ANZET 21. Virtual, Online. 30(Supplement 3) (pp S308-S309), 2021. Date of Publication: January 2021.
Journal: Heart Lung and Circulation
Abstract: Background: While hypo-attenuated leaflet thickening (HALT) has been extensively described following transcatheter aortic valve replacement (TAVR), it remains unclear whether HALT impacts long-term prosthetic haemodynamics or predicts structural valve deterioration (SVD). Method(s): We prospectively evaluated 186 patients who had undergone TAVR with 320-slice CT imaging for the presence of HALT, defined as hypo-attenuation of bioprosthetic leaflets in diastole. HALT depth was the greatest depth in the sagittal view and HALT area was the greatest area in the axial view. SVD was defined as at least one of mean gradient >=20 mmHg, increase in gradient >=10 mmHg from baseline, and at least moderate valvular regurgitation. Echocardiograms at discharge, one month, and annually were assessed by cardiologists blinded to HALT status. Result(s): Leaflet thickening prevalence was 17.7% at a median CT scan of 6 weeks. SVD occurred in 8.6% at a median follow-up of 2 years (IQR, 1-3); two required valve re-intervention, five required anticoagulation that reversed moderate-severe gradient, and nine had mild-moderate gradients that were closely monitored. Patients with HALT were more likely to develop SVD (39.3% vs 1.9%; p<0.01) and higher transvalvular gradients throughout follow-up (Figure 1). HALT affected one leaflet in 17 cases, two leaflets in 13 cases, and three leaflets in three cases. Patients with HALT had a median cumulative thickness of 2.9 mm (IQR, 1.9-4.7) and a median area of 64.2 mm2 (IQR, 40.9-91.6). Threshold for the occurrence of SVD with HALT characteristics were cumulative depth of 2.4 mm (specificity 94.1%, sensitivity 75.0%, and AUC=0.87) and cumulative area of 28 mm2 (specificity 92.2%, sensitivity 81.3%, and AUC=0.86). Conclusion(s): HALT was associated with SVD and higher transvalvular gradients following TAVR. HALT depth and area were strong predictors of SVD. CT following TAVR may determine patients at-risk of SVD.Copyright © 2021
Conference Name: 69th CSANZ Annual Scientific Meeting 43rd Annual Scientific Meeting of the International Society for Heart Research ANZET 21
Conference Start Date: 20210-08-05
Conference End Date: 20210-08-08
Conference Location: Virtual, Online
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/j.hlc.2021.06.481
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/46843
Type: Conference Abstract
Subjects: adverse device effect
anticoagulation
cardiologist
diastole
echocardiography
thickness
transcatheter aortic valve implantation
valve deterioration
x-ray computed tomography
Appears in Collections:Conferences

Show full item record

Page view(s)

80
checked on May 31, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.